Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             27 results found
no title author magazine year volume issue page(s) type
1 A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium von der Maase, H.

17 10 p. 1533-1538
article
2 Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer Sanna, G.

17 10 p. 1512-1516
article
3 Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: are these nodes to be considered negative? van Akkooi, A.C.J.

17 10 p. 1578-1585
article
4 Does low-molecular-weight heparin influence cancer-related mortality? Ferretti, G.

17 10 p. 1604-1606
article
5 Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study Schadendorf, D.

17 10 p. 1592-1597
article
6 Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy Malamou-Mitsi, V.

17 10 p. 1504-1511
article
7 Factorial design for randomized clinical trials Bria, E.

17 10 p. 1607-1608
article
8 FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients Berretta, M.

17 10 p. 1606-1607
article
9 High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults Pedrazzoli, P.

17 10 p. 1479-1488
article
10 in this issue
17 10 p. 1473
article
11 Long-term cardiac follow-up in survivors of a malignant bone tumour Brouwer, C.A.J.

17 10 p. 1586-1591
article
12 Mediastinal mature teratoma with an immature component—what about the treatment? Romagnani, E.

17 10 p. 1602-1604
article
13 Merkel cell cancer of the skin Pectasides, D.

17 10 p. 1489-1495
article
14 Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome Wang, L.

17 10 p. 1517-1522
article
15 Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group Fountzilas, G.

17 10 p. 1560-1567
article
16 Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study Koopman, M.

17 10 p. 1523-1528
article
17 Real-time PCR analysis of PML-RARα in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy Ghaffari, S.H.

17 10 p. 1553-1559
article
18 Reply to Letter to the Editor: ‘Toxic epidermal necrolysis in patients with malignancies’, by G. Gravante, G. Esposito, M. Marianetti, D. Delogu, G. Sconocchia & A. Montone (doi:10.1093/annonc/mdl089) Curigliano, G.

17 10 p. 1601-1602
article
19 Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease Colleoni, M.

17 10 p. 1497-1503
article
20 Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL) Betticher, D.C.

17 10 p. 1546-1552
article
21 Table of Contents
17 10 p. ii-iii
article
22 The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR Pfisterer, J.

17 10 p. 1568-1577
article
23 The challenge of nephroblastoma in a developing country Ekenze, S.O.

17 10 p. 1598-1600
article
24 The enigma of young age Aebi, S.

17 10 p. 1475-1477
article
25 The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma Giné, E.

17 10 p. 1539-1545
article
26 Toxic epidermal necrolysis in patients with malignancies Gravante, G.

17 10 p. 1601
article
27 Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study Orditura, M.

17 10 p. 1529-1532
article
                             27 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands